Research ArticleCORONAVIRUS

Potency and timing of antiviral therapy as determinants of duration of SARS-CoV-2 shedding and intensity of inflammatory response

See allHide authors and affiliations

Science Advances  20 Nov 2020:
Vol. 6, no. 47, eabc7112
DOI: 10.1126/sciadv.abc7112

Article Information

vol. 6 no. 47

PubMed: 
Online ISSN: 
History: 
  • Received for publication May 8, 2020
  • Accepted for publication October 7, 2020
  • .

Article Versions

Author Information

  1. Ashish Goyal1,*,
  2. E. Fabian Cardozo-Ojeda1,* and
  3. Joshua T. Schiffer1,2,3,
  1. 1Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  2. 2Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  3. 3Department of Medicine, University of Washington, Seattle, WA, USA.
  1. Corresponding author. Email: jschiffe{at}fredhutch.org
  • * These authors contributed equally to this work.

Altmetric

Article usage

Article usage: October 2020 to February 2021

AbstractFullPdf
Oct 2020303999690
Nov 20201355309764
Dec 2020581385279
Jan 2021461908237
Feb 2021491282146

Stay Connected to Science Advances

Navigate This Article